Xeris Pharmaceuticals (XERS)
(Real Time Quote from BATS)
$1.78 USD
0.00 (0.00%)
Updated Apr 24, 2024 01:56 PM ET
4-Sell of 5 4
D Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, Xeris Pharmaceuticals (XERS) reported earnings of -$0.10 per share, missing the Zacks Consensus Estimate of -$0.09 per share. This reflects a negative earnings surprise of 11.11%. Look out for XERS's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for XERS
Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
XERS: What are Zacks experts saying now?
Zacks Private Portfolio Services